Groupe d' Etude des Protéines Membranaires (GEPROM), département de Physiologie, Université de Montréal, Montréal, Québec, Canada.
J Physiol. 2010 Jun 15;588(Pt 12):2205-18. doi: 10.1113/jphysiol.2010.187674. Epub 2010 Apr 19.
Aquaporin-2 (AQP2), located at the luminal side of the collecting duct principal cells, is a water channel responsible for the final concentration of urine. Lack of function, often occurring through mistargeting of mutated proteins, induces nephrogenic diabetes insipidus (NDI), a condition characterized by large urinary volumes. In the present study, two new mutations (K228E and V24A) identified in NDI-affected individuals from distinct families along with the already reported R187C were analysed in comparison to the wild-type protein (AQP2-wt) using Xenopus laevis oocytes and a mouse collecting duct cell-line (mIMCD-3). Initial data in oocytes showed that all mutations were adequately expressed at reduced levels when compared to AQP2-wt. K228E and V24A were found to be properly targeted at the plasma membrane and exhibited adequate functionality similar to AQP2-wt, as opposed to R187C which was retained in internal stores and was thus inactive. In coexpression studies using oocytes, R187C impeded the functionality of all other AQP2 variants while combinations with K228E, V24A and AQP2-wt only showed additive functionalities. When expressed in mIMCD-3 cells, forskolin treatment efficiently promoted the targeting of AQP2-wt at the plasma membrane (>90%) while K228E only weakly responded to the same treatment (approximately 20%) and both V24A and R187C remained completely insensitive to the treatment. We concluded that both V24A and K228E are intrinsically functional water channels that lack a proper response to vasopressin, which leads to NDI as found in both compound mutations studied (K228E + R187C and V24A + R187C). The discrepancies in plasma membrane targeting response found in both expression systems stress the need to evaluate such data using mammalian cell systems.
水通道蛋白-2(AQP2)位于集合管主细胞的管腔侧,是负责尿液最终浓缩的水通道。功能缺失,通常通过突变蛋白的靶向错误发生,导致肾性尿崩症(NDI),其特征是尿量较大。在本研究中,我们分析了来自不同家族的 NDI 患者中鉴定出的两种新突变(K228E 和 V24A),以及已经报道的 R187C,与野生型蛋白(AQP2-wt)进行比较,使用非洲爪蟾卵母细胞和小鼠集合管细胞系(mIMCD-3)。在卵母细胞中的初始数据表明,与 AQP2-wt 相比,所有突变体的表达水平均降低。发现 K228E 和 V24A 被正确靶向质膜,并表现出与 AQP2-wt 相似的适当功能,而 R187C 则保留在内质网中,因此无功能。在使用卵母细胞的共表达研究中,R187C 阻碍了所有其他 AQP2 变体的功能,而与 K228E、V24A 和 AQP2-wt 的组合仅显示出加性功能。在 mIMCD-3 细胞中表达时,forskolin 处理有效地促进了 AQP2-wt 在质膜上的靶向(>90%),而 K228E 仅对相同处理有弱反应(约 20%),V24A 和 R187C 对处理完全不敏感。我们得出结论,K228E 和 V24A 都是内在功能的水通道,缺乏对血管加压素的适当反应,这导致了在研究的两种复合突变(K228E + R187C 和 V24A + R187C)中发现的 NDI。在两种表达系统中发现的质膜靶向反应差异强调了需要使用哺乳动物细胞系统评估此类数据的必要性。